Clinical Trials Directory

Trials / Conditions / Pathologic Stage III Gastric Cancer AJCC v8

Pathologic Stage III Gastric Cancer AJCC v8

9 registered clinical trials studyying Pathologic Stage III Gastric Cancer AJCC v8 — 2 currently recruiting.

StatusTrialSponsorPhase
WithdrawnNeoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
NCT05296005
Ohio State University Comprehensive Cancer CenterPhase 1
RecruitingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno
NCT05041153
M.D. Anderson Cancer CenterEARLY_Phase 1
RecruitingRamucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv
NCT04660760
Academic and Community Cancer Research UnitedPhase 2
Active Not RecruitingA Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
NCT04111172
Thomas Jefferson UniversityPhase 2
Active Not RecruitingShort-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma
NCT04523818
M.D. Anderson Cancer CenterPhase 1
CompletedReal-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study
NCT04449679
Thomas Jefferson UniversityN/A
CompletedRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
NCT04501913
City of Hope Medical Center—
Active Not RecruitingEarly Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric C
NCT03997162
City of Hope Medical Center—
CompletedPembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma
NCT03395847
M.D. Anderson Cancer CenterEARLY_Phase 1